$STEX

Streamex is making digital gold accessible

Streamex Corp. (NASDAQ: STEX) said its gold-backed tokenized security $GLDY can now be bought through ordinary brokerage accounts via a collaboration with Siebert Financial and tZERO. $GLDY pays yield up to ~3.5% annually, distributed monthly in additional gold, and is currently available to verified accredited investors.

Original reporting
Published Jul 1, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Streamex is making digital gold accessible — source image
Decision brief

The 30-second read

$STEXBullishMed
01

Why it matters

By enabling $GLDY purchases through a traditional brokerage account, Streamex reduces onboarding friction for conventional investors and wealth managers, potentially improving distribution efficiency while keeping the product within regulated security boundaries.

02

Market read

Traders may view the brokerage-access update as a tangible step toward mainstream distribution for tokenized gold, but the article lacks flow/financial metrics to gauge magnitude.

03

What to watch

No data is provided on brokerage take-up, AUM growth, redemption/liquidity mechanics, or regulatory/operational risks of tokenized custody—key drivers of whether distribution translates into revenue.

Relevance 7/10Novelty 6/10Timing: June 29 announcement that $GLDY is now purchasable in regular brokerage accounts.

Background

The article frames Streamex’s effort to make gold exposure easier by moving from physical/ETF trade-offs to a tokenized, yield-bearing security.

Company-level read

Ticker impact

$STEXBullishMedium confidence
Context

Streamex says its gold-backed token $GLDY can now be bought through an ordinary brokerage account via Siebert, expanding distribution.

Expected impact

Moderately positive bias for STEX as investors price in wider access and potential AUM growth, though constrained by accredited-investor limits.

Evidence & confidence

The article is a first report of a new distribution channel (brokerage accounts) and provides yield/structure details, but it does not quantify incremental flows or provide financial guidance.

Market effects

Supports the broader RWA/tokenized-commodities distribution thesis by showing regulated brokerage rails can be used for tokenized gold.

Primarily US-focused via FINRA-member broker distribution; could influence US wealth-management interest in tokenized commodities.

If replicated internationally, could increase global accessibility to yield-bearing tokenized gold, but the article emphasizes Solana-based trading for cross-border access.

Counterpoint

The impact may be limited because $GLDY remains restricted to verified accredited investors, so near-term addressable demand could be smaller than the marketing implies.

Key entities

  • Streamex Corp.

    Issuer of the gold-backed tokenized security $GLDY (NASDAQ: STEX).

  • $GLDY

    Gold-backed, tokenized yield-bearing security paying monthly yield in additional gold; now available via ordinary brokerage accounts for accredited investors.

  • Siebert Financial

    FINRA-member broker handling distribution for $GLDY.

  • tZERO

    Regulated digital-securities platform custodian for the asset.

  • Orca (Solana DEX)

    Mentioned as enabling 24/7 secondary trading for $GLDY since May.

Related articles

$STEXLow

Streamex Corp. (STEX): Results of Operations and Financial Condition

Streamex Corp. (STEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Streamex Corp. Reports Second Quarter 2026 Financial Results WINTER PARK, Fla., August 17, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, tod

$STEXMed

Streamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with Wintermute

Streamex Corp. (NASDAQ: STEX) said it expanded 24/7, T+0 liquidity for GLDY, its gold-backed yield-bearing token, by adding Wintermute as a continuous liquidity provider. Streamex seeded 1,069 GLDY and $5 million USDC, bringing secondary liquidity to about $12 million. Purchases and redemptions now settle instantly via the Streamex interface, with a 1,000 GLDY or $4.5 million per 48-hour limit per order.

$STEXMed

Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

Streamex Corp. (NASDAQ: STEX) said it appointed Kori Handy as Vice President of Product and Design. The company said Handy has 18 years of fintech/SaaS product experience, including scaling platforms to $2B+ in assets under management and 200M+ users. Streamex said he previously led redesigns at Groundfloor, driving a 32% activation increase and 27% higher cash deposits. He will oversee the GLDY user experience and future tokenized real-asset product launches.

$NVDALowAI 8/10

NVIDIA's $99 Billion AI Portfolio: Every Major Investment in 2026

NVIDIA's equity investments in AI companies totaled $99 billion, up from $7 billion a year ago. Key investments include OpenAI ($30B), Hugging Face ($12.9B), and Anthropic ($10B). The company's Q2 2027 revenue was $96.2B, up 106% YoY, with data center revenue at $89B, up 117%. NVIDIA is also involved in $500B in AI infrastructure financing. Investments aim to secure customers, create dependencies, and gain equity upside, but also expose NVIDIA to market risks and potential regulatory scrutiny.

$CYTKMedAI 8/10

Could Aficamten Give Cytokinetics the First Approved nHCM Treatment?

Cytokinetics (NASDAQ:CYTK) reported late-stage trial results for aficamten in non-obstructive hypertrophic cardiomyopathy (nHCM), meeting primary goals of improving symptoms and quality of life. The study showed 53% of patients on aficamten improved in key areas vs. 13% on placebo, but lacked significant structural or cardiovascular benefits. The company plans a US marketing application in Q4 2026. Analysts forecast peak sales of over $5 billion for Myqorzo, but investors expressed concerns over

$CCJMed

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.